Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare Conference

world news, trump, u.s., business news, stock market, entertainment news, business news, company news, market, commodities, commodity, Africa news

WESTLAKE VILLAGE, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) — Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA), a clinical-stage medical dermatology and aesthetics company, today announced that Frederick C. Beddingfield III,…

Advertisements